Were you looking for information about Cabozantinib? Cabozantanib is a common misspelling of cabozantinib.
Cabozantinib (Cometriq™) is a chemotherapy medication approved to treat medullary thyroid cancer in adults. It is reserved for use when the cancer has progressed and spread to other areas of the body (metastasized).
This medicine can cause significant side effects, so contact your healthcare provider right away if you develop any signs of an infection or other serious problems. Cabozantinib comes as a capsule that is taken once daily.
(For more information on this medicine, click Cabozantinib. This full-length article offers a complete overview of this product, including safety concerns, potential side effects, and general dosing instructions. You can also click any of the links in the box to the right for specific information.)